Dr Natalia Povolotskaya : Obstetrics and gynaecology

Home
Dr Natalia Povolotskaya

Fee assured
Verified account
Open Referral network

Overview

Specialises in

Gynaecological oncology

Gynaecology

Offers

Video and telephone consultations

Medical secretaries

Julie Chaffey
Doric House 7 Ellesmere Orchard Emsworth PO10 8TP
0330 118 5037
hello@themedicalpa.co.uk

About me

(Additional) Languages spoken

Publications

Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series - Natalia Povolotskaya , Robert Woolas, Dirk Brinkmann
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Chiva L, and SUCCOR study Group.Int J Gynecol Cancer. 2020 Sep;30(9):1269-1277. doi: 10.1136/ijgc-2020-001506. Epub 2020 Aug 11.PMID: 32788262 3
• SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer. Boria F, Chiva L, SUCCOR study Group.Int J Gynecol Cancer. 2022 Oct 3;32(10):1236-1243. doi: 10.1136/ijgc-2022-003790.PMID: 36583728 4
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer. Manzour N, Chiva L at ell and SUCCOR Study Group.Ann Surg Oncol. 2022 Aug;29(8):4819-4829. doi: 10.1245/s10434-022-11671-5. Epub 2022 Apr 16.PMID: 35430668 Free PMC article. 5
• Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study. Gaba F, Goyal S, Marks D, Chandrasekaran D, Evans O, Robbani S, Tyson C, Legood R, Saridogan E, McCluggage WG, Hanson H, Singh N, Evans DG, Menon U, Manchanda R; PROTECTOR team.J Med Genet. 2022 Feb;59(2):
• Post-coital bleeding: What is the incidence of significant gynaecological pathology in women referred for colposcopy? Godfrey MAL, Nikolopoulos M, Povolotskaya N, Chenoy R, Wuntakal R.Sex Reprod Healthc. 2019 Dec;22:100462.
• Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial. Gaba F, Robbani S, Singh N, McCluggage WG, Wilkinson N, Ganesan R, Bryson G, Rowlands G, Tyson C, Arora R, Saridogan E, Hanson H, Burnell M, Legood R, Evans DG, Menon U, Manchanda R; PROTECTOR team.Int J Gynecol Cancer. 2021 Feb;31(2):
• Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series. Povolotskaya N, Woolas R, Brinkmann D.Int J Surg Oncol. 2015;
• Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer N Povolotskaya, N Das, K Dhar, D Brinkmann, F Gardner, R Woolas

My qualifications & training

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

P2730
Colposcopy (+/- biopsy, polypectomy or vulvoscopy) - (1-5)

Spire Portsmouth Hospital (1-5)
Q0711
Robotic assisted radical hysterectomy and lymphadenectomy (Wertheim's) +/- ureterolysis - (1-5)
Q0791
Robotic assisted laparoscopic total hysterectomy (+/- oophorectomy) - (1-5)
Q2020
Endometrial biopsy or aspiration - (1-5)

Spire Portsmouth Hospital (1-5)
P0580
Radical vulvectomy (including block dissection of inguinal gland) - (1-5)
Q1800
Hysteroscopy (including biopsy, dilatation, +/- cauterisation, curettage and resection of polyp(s) +/- Mirena coil insertion) - (1-5)
P0600
Excision of lesion of vulva - (1-5)
Show All (7 )...

Report this page Print page

Finder

Note: